Comparison of circulation patterns of mumps virus in the Netherlands and Spain (2015-2020).
MF-NCR sequence
SH sequence
Spain
laboratory surveillance
molecular epidemiology
mumps virus
the Netherlands
Journal
Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977
Informations de publication
Date de publication:
2023
2023
Historique:
received:
17
04
2023
accepted:
22
05
2023
medline:
3
7
2023
pubmed:
3
7
2023
entrez:
3
7
2023
Statut:
epublish
Résumé
Mumps is a viral infection mainly characterized by inflammation of the parotid glands. Despite of vaccination programs, infections among fully vaccinated populations were reported. The World Health Organization (WHO) recommends molecular surveillance of mumps based on sequencing of the small hydrophobic (SH) gene. The use of hypervariable non-coding regions (NCR) as additional molecular markers was proposed in multiple studies. Circulation of mumps virus (MuV) genotypes and variants in different European countries were described in the literature. From 2010 to 2020, mumps outbreaks caused by genotype G were described. However, this issue has not been analyzed from a wider geographical perspective. In the present study, sequence data from MuV detected in Spain and in The Netherlands during a period of 5 years (2015- March 2020) were analyzed to gain insights in the spatiotemporal spread of MuV at a larger geographical scale than in previous local studies. A total of 1,121 SH and 262 NCR between the Matrix and Fusion protein genes (MF-NCR) sequences from both countries were included in this study. Analysis of SH revealed 106 different haplotypes (set of identical sequences). Of them, seven showing extensive circulation were considered variants. All seven were detected in both countries in coincident temporal periods. A single MF-NCR haplotype was detected in 156 sequences (59.3% of total), and was shared by five of the seven SH variants, as well as three minor MF-NCR haplotypes. All SH variants and MF-NCR haplotypes shared by both countries were detected first in Spain. Our results suggest a transmission way from south to north Europe. The higher incidence rate of mumps in Spain in spite of similar immunization coverage in both countries, could be associated with higher risk of MuV exportation. In conclusion, the present study provided novel insights into the circulation of MuV variants and haplotypes beyond the borders of single countries. In fact, the use of MF-NCR molecular tool allowed to reveal MuV transmission flows between The Netherlands and Spain. Similar studies including other (European) countries are needed to provide a broader view of the data presented in this study.
Sections du résumé
Background
UNASSIGNED
Mumps is a viral infection mainly characterized by inflammation of the parotid glands. Despite of vaccination programs, infections among fully vaccinated populations were reported. The World Health Organization (WHO) recommends molecular surveillance of mumps based on sequencing of the small hydrophobic (SH) gene. The use of hypervariable non-coding regions (NCR) as additional molecular markers was proposed in multiple studies. Circulation of mumps virus (MuV) genotypes and variants in different European countries were described in the literature. From 2010 to 2020, mumps outbreaks caused by genotype G were described. However, this issue has not been analyzed from a wider geographical perspective. In the present study, sequence data from MuV detected in Spain and in The Netherlands during a period of 5 years (2015- March 2020) were analyzed to gain insights in the spatiotemporal spread of MuV at a larger geographical scale than in previous local studies.
Methods
UNASSIGNED
A total of 1,121 SH and 262 NCR between the Matrix and Fusion protein genes (MF-NCR) sequences from both countries were included in this study. Analysis of SH revealed 106 different haplotypes (set of identical sequences).
Results
UNASSIGNED
Of them, seven showing extensive circulation were considered variants. All seven were detected in both countries in coincident temporal periods. A single MF-NCR haplotype was detected in 156 sequences (59.3% of total), and was shared by five of the seven SH variants, as well as three minor MF-NCR haplotypes. All SH variants and MF-NCR haplotypes shared by both countries were detected first in Spain.
Discussion
UNASSIGNED
Our results suggest a transmission way from south to north Europe. The higher incidence rate of mumps in Spain in spite of similar immunization coverage in both countries, could be associated with higher risk of MuV exportation. In conclusion, the present study provided novel insights into the circulation of MuV variants and haplotypes beyond the borders of single countries. In fact, the use of MF-NCR molecular tool allowed to reveal MuV transmission flows between The Netherlands and Spain. Similar studies including other (European) countries are needed to provide a broader view of the data presented in this study.
Identifiants
pubmed: 37396375
doi: 10.3389/fmicb.2023.1207500
pmc: PMC10311905
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1207500Informations de copyright
Copyright © 2023 Gavilán, van de Nes-Reijnen, Castellanos, Woudenberg, López-Perea, Masa-Calles, Echevarría, Fernández-García and Bodewes.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Euro Surveill. 2010 Apr 29;15(17):
pubmed: 20460086
Rev Med Virol. 2015 Mar;25(2):85-101
pubmed: 25424978
Vaccine. 2017 Aug 3;35(34):4339-4345
pubmed: 28687402
Vaccine. 2001 Feb 8;19(13-14):1727-31
pubmed: 11166897
Emerg Infect Dis. 2014 Apr;20(4):643-8
pubmed: 24655811
PLoS One. 2020 Sep 14;15(9):e0233143
pubmed: 32925979
Vaccine. 2012 Jun 29;30(31):4676-80
pubmed: 22579874
BMC Infect Dis. 2020 Mar 26;20(1):244
pubmed: 32216754
J Pathol. 2015 Jan;235(2):242-52
pubmed: 25229387
Euro Surveill. 2018 Apr;23(15):
pubmed: 29667574
Vaccine. 2011 Nov 15;29(49):9271-5
pubmed: 21983156
Am J Epidemiol. 1995 Aug 1;142(3):233-53; discussion 231-2
pubmed: 7631629
Vaccine. 2014 Jul 31;32(35):4393-4398
pubmed: 24973734
J Clin Virol. 2011 Dec;52(4):359-62
pubmed: 21975077
Epidemiol Infect. 2003 Aug;131(1):703-9
pubmed: 12948370
Infect Chemother. 2015 Mar;47(1):1-11
pubmed: 25844258
J Med Virol. 2019 Mar;91(3):347-350
pubmed: 30252936
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
PLoS One. 2015 Oct 23;10(10):e0139815
pubmed: 26496490
Epidemiol Infect. 2017 Nov;145(15):3219-3225
pubmed: 28903791
J Infect Dis. 2022 Dec 28;227(1):151-160
pubmed: 35524966
Vaccine. 2010 Apr 9;28(17):2932-6
pubmed: 20188683
Euro Surveill. 2018 Sep;23(38):
pubmed: 30255834
BMC Infect Dis. 2021 Oct 4;21(1):1035
pubmed: 34607555
Clin Microbiol Rev. 2020 Feb 26;33(2):
pubmed: 32102901
Nucleic Acids Res. 2016 Jul 8;44(W1):W232-5
pubmed: 27084950
Mol Biol Evol. 2018 Feb 1;35(2):518-522
pubmed: 29077904
Euro Surveill. 2017 Aug 31;22(35):
pubmed: 28877843
J Clin Microbiol. 2010 Apr;48(4):1245-54
pubmed: 20107099
Epidemiol Infect. 2013 Jun;141(6):1298-309
pubmed: 22954346